Cite
HARVARD Citation
Sirima, S. et al. (2017). Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age. Pediatric infectious disease journal. 36 (5), p. . [Online].